Loading market dashboard
Quoin Pharmaceuticals, Ltd.
QNRXHealthcareNASDAQUS
Loading analysis workspace
Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Quoin Pharmaceuticals, Ltd. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $85.97M | $65.10M - $106.84M | $0.00 | $2.87 | 1 |
| Dec 2029 | $50.10M | $37.94M - $62.26M | $0.00 | $1.12 | 2 |
| Dec 2028 | $20.74M | $15.71M - $25.78M | $0.00 | -$1.54 | 3 |
| Dec 2027 | $12.12M | $9.17M - $15.06M | $0.00 | -$3.54 | 3 |
| Dec 2026 | $13.05M | $9.89M - $16.22M | $0.00 | -$6.48 | 3 |
| Dec 2025 | $15.58M | $11.80M - $19.36M | $0.00 | -$20.155 | 1 |
| Dec 2024 | $0.00 | $0.00 - $0.00 | $0.00 | -$72.80 | 0 |
| Dec 2020 | $3.75M | $2.84M - $4.66M | $0.00 | -$5,670.00 | 1 |
| Dec 2019 | $1.00M | $757.3K - $1.24M | $0.00 | -$6,405.00 | 1 |
| Dec 2018 | $250.0K | $189.3K - $310.7K | $0.00 | -$5,617.50 | 1 |